Inventor · disambiguated record
Everett Stone
Also filed as: STONE EVERETT · STONE EVERETT W
34 granted patents·12 pending applications·188 citations·filing 1980–2023
97Inventor score
Top patents by PatentIndex Score
46 records- 0195US10772913B2Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2019·Granted Sep 15, 2020·5 cites·19 claims
- 0295US8440184B2Compositions of engineered human arginases and methods for treating cancerGEORGIOU GEORGE·Filed 2009·Granted May 14, 2013·19 cites·5 claims
- 0394US9808486B2Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2014·Granted Nov 7, 2017·17 cites·16 claims
- 0493US10098933B2Compositions of engineered human arginases and methods for treating cancerAERASE INC·Filed 2016·Granted Oct 16, 2018·4 cites·3 claims
- 0593US9975959B2Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2015·Granted May 22, 2018·8 cites·16 claims
- 0693US9909163B2Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereofAEMASE INC·Filed 2016·Granted Mar 6, 2018·11 cites·2 claims
- 0793US9624484B2Engineered primate L-methioninase for therapeutic purposesUNIV TEXAS·Filed 2016·Granted Apr 18, 2017·11 cites·12 claims
- 0893US8709407B2Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereofGEORGIOU GEORGE·Filed 2011·Granted Apr 29, 2014·17 cites·19 claims
- 0992US9481877B2Engineered primate L-methioninase for therapeutic purposesUNIV TEXAS·Filed 2014·Granted Nov 1, 2016·14 cites·19 claims
- 1091US11168142B2Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2018·Granted Nov 9, 2021·5 cites·20 claims
- 1191US9279119B2Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereofAEMASE INC·Filed 2014·Granted Mar 8, 2016·11 cites·12 claims
- 1290US10233438B2Engineered primate L-methioninase for therapeutic purposesUNIV TEXAS·Filed 2017·Granted Mar 19, 2019·6 cites·18 claims
- 1389US11118167B2Enzyme-mediated depletion of adenosine and/or methylthioadenosineUNIV TEXAS·Filed 2020·Granted Sep 14, 2021·3 cites·15 claims
- 1489US10716856B2Engineered primate cystine/cysteine degrading enzymes as antineogenic agentsUNIV TEXAS·Filed 2019·Granted Jul 21, 2020·2 cites·11 claims
- 1588USRE46423ECompositions of engineered human arginases and methods for treating cancerAERASE INC·Filed 2015·Granted Jun 6, 2017·2 cites·11 claims
- 1688US9050340B2Compositions of engineered human arginases and methods for treating cancerAERASE INC·Filed 2013·Granted Jun 9, 2015·7 cites·11 claims
- 1788US8679479B2Methods for purifying pegylated arginaseGEORGIOU GEORGE·Filed 2010·Granted Mar 25, 2014·11 cites·9 claims
- 1887US11534463B2Nucleic acids encoding kynurenine depleting enzymesUNIV TEXAS·Filed 2020·Granted Dec 27, 2022·1 cites·14 claims
- 1985US11648272B2Human kynureninase enzymes and uses thereofUNIV TEXAS·Filed 2019·Granted May 16, 2023·2 cites·20 claims
- 2085US10526638B2Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereofAEMASE INC·Filed 2018·Granted Jan 7, 2020·3 cites·8 claims
- 2185US2024009283A1Compositions Of Engineered Human Arginases And Methods For Treating CancerAERASE INC·Filed 2023·Application pending·0 cites
- 2283US10724026B2Engineered primate L-methioninase for therapeutic purposesUNIV TEXAS·Filed 2019·Granted Jul 28, 2020·2 cites·17 claims
- 2383US10363311B2Engineered primate cystine/cysteine degrading enzymes as antineogenic agentsUNIV TEXAS·Filed 2014·Granted Jul 30, 2019·4 cites·12 claims
- 2482US2024091258A1Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2022·Application pending·0 cites
- 2576US11542486B2Human kynureninase enzyme variants having improved pharmacological propertiesUNIV TEXAS·Filed 2017·Granted Jan 3, 2023·1 cites·13 claims
- 2675US12144828B2Human Kynureninase enzymes and uses thereofUNIV TEXAS·Filed 2023·Granted Nov 19, 2024·0 cites·18 claims
- 2775US10865403B2Engineered primate cystine/cysteine degrading enzymes for therapeutic usesUNIV TEXAS·Filed 2018·Granted Dec 15, 2020·1 cites·36 claims
- 2874US11597916B2Nicotine degrading enzyme variantsANTIDOTE THERAPEUTICS INC·Filed 2018·Granted Mar 7, 2023·1 cites·24 claims
- 2973US2021128703A1Compositions Of Engineered Human Arginases And Methods For Treating CancerGEORGIOU GEORGE·Filed 2020·Application pending·0 cites
- 3071US11591579B2Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapyUNIV TEXAS·Filed 2021·Granted Feb 28, 2023·0 cites·19 claims
- 3171US11396647B2Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapyUNIV TEXAS·Filed 2021·Granted Jul 26, 2022·0 cites·19 claims
- 3271US2019000939A1Compositions of engineered human arginases and methods for treating cancerAERASE INC·Filed 2018·Application pending·0 cites
- 3371US2023227796A1Enzyme-mediated depletion of adenosine and/or methylthioadenosineUNIV TEXAS·Filed 2022·Application pending·0 cites
- 3470US12036269B2Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuriaUNIV TEXAS·Filed 2021·Granted Jul 16, 2024·0 cites·16 claims
- 3570US11584949B2Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereofAEMASE INC·Filed 2019·Granted Feb 21, 2023·0 cites·19 claims
- 3670US11426464B2Engineered primate cystine/cysteine degrading enzymes as antineogenic agentsUNIV TEXAS·Filed 2020·Granted Aug 30, 2022·0 cites·18 claims
- 3770US2022275099A1Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2021·Application pending·0 cites
- 3867US2023416697A1Novel nicotine degrading enzyme variantsANTIDOTE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3966US11033612B2Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuriaUNIV TEXAS·Filed 2018·Granted Jun 15, 2021·0 cites·34 claims
- 4064US2014242060A1Compositions of engineered human arginases and methods for treating cancerAERASE INC·Filed 2014·Application pending·0 cites
- 4160US12163168B2Engineered primate cystine/cysteine degrading enzymes for therapeutic usesUNIV TEXAS·Filed 2019·Granted Dec 10, 2024·0 cites·34 claims
- 4260US4293578AMethod of treating fresh shrimp to reduce moisture and nutrient lossSTONE EVERETT W·Filed 1980·Granted Oct 6, 1981·20 cites·16 claims
- 4360US2021054350A1Enzyme-mediated depletion of adenosine and/or methylthioadenosineUNIV TEXAS·Filed 2018·Application pending·0 cites
- 4459US2017056449A1Administration of kynurenine depleting enzymes for tumor therapyUNIV TEXAS·Filed 2016·Application pending·0 cites
- 4548US2009238813A1Compositions And Methods For Engineered Human Arginine DeiminasesUNIV TEXAS·Filed 2008·Application pending·0 cites
- 4642US2018008681A1Human-enzyme mediated depletion of cystine for treating patients with cystinuriaUNIV TEXAS·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →